http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008262245-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e75c02462873e05b3f94b2cc9636471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2988cc41ae6d732d3c4017dabe6ee416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f93e7951fb0586f1fc49f0a6e32543c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3be764c626ebb8bbd1b7c02c0276b87
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
filingDate 2004-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af243e19e0fc9e7e9ce7e611c6233c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c7ec82901173e48ef97124b3330d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c87da0ba89030b694cd5a986ab8e9d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ddcc9655cf1828f3224a7c5bd7423ee
publicationDate 2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008262245-A1
titleOfInvention Process for the Preparation of Amorphous Fluvastatin Sodium
abstract The present invention relates to a novel process for the preparation of the HMG-CoA reductase inhibitor, fluvastatin, more specifically to a process for the preparation of amorphous form of fluvastatin sodium.
priorityDate 2004-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4739073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7414140-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23679527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9932627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127856099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9954640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127856101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413550029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009

Total number of triples: 53.